Together against cancer

Newsletter October 2020

Topics that will be discussed.

  • New webinar Preclinical Evaluation of Anti-metastatic Drug Candidates using a Next-Generation Chicken Embryo Model
  • The latest publication led by Dr. Anna Halama, Assistant Professor of Research in Physiology & Biophysics
  • R&D Booster project: a 900k€ project for deepening our understanding of cancer mechanisms and other diseases
  • FAQ: Can experiments to study metastasis be conducted on Inovotion's model?

Read more

pipette

Newsletter July 2020

Topics that will be discussed.

  • Webinar: how to optimize in vivo preclinical efficacy evaluation of synergistic immuno-oncology drug candidates
  • New publication: Inhibition of patched drug efflux increases vemurafenib effectiveness against resistant brafv600e melanoma 
  • Free webinar: combination approach: a breakthrough in vivo model for high-value identification of oncology candidates
  • New standardised cell lines
  • Faq: Is the chicken embryo model considered animal testing? Do you need to address ethical regulations to perform studies on the chicken embryo model?

Read more

molecules

Newsletter December 2019

Topics that will be discussed.

  • Inovotion is showcasing its technology via the NC3Rs’ CRACK IT Solutions partnering programme.
  • Jean Viallet, INOVOTION’s CEO and founder, invited to testify on technology transfer, met Frédérique Vidal, French Minister for Advanced Education, Research and Innovation
  • Chick Embryo Chorioallantoic Membrane: a suitable and easy-to-use model for Photodynamic Therapies. An article from the University of Coimbra
  • New standardized cell lines
  • FAQ: Is the chicken embryo model considered animal testing? Do you need to address ethical regulations to perform studies on the chicken embryo model?

Read more

neurone

Newsletter May 2019

Topics that will be discussed.

  • New cancer model for in vivo efficacy evaluation in the chicken embryo model: effect of cytarabine on the acute myeloid leukemia (aml) cell line mv4-11
  • A real in vivo model without regulatory constraints.
  • Presentation by jean viallet, phd, inovotion’s founder, on anti-pd-1/anti-pd-l1 therapies at the meet2win conference.
  • Ais 2019: inovotion will give a talk and introduce latest developments in in vivo efficacy and safety screening.
  • Latest developed cell lines
  • Events – where to meet us

Read more

blocs

Newsletter February 2019

Topics that will be discussed.

  • Early in vivo evaluation assays for immune-modulation of anti-PD-1 / anti-PD-L1 based combinations.
  • More than 40 cell lines and 17 reference compounds tested and ready to use for efficacy assays
  • Publication featuring INOVOTION’s platform: Genoscience Pharma evaluated their most advanced compound, GNS561, with the chick embryo model
  • Events – Where to meet us

Read more

Register for our Newsletter